Combat Medical just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Combat Medical, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
Only Fundz delivers all four.
Combat Medical raises £2.6 million in Series A funding led by T&J Meyer Family Foundation to advance its HIVEC treatment for bladder cancer.
Amount Raised
£2.6 Million
Round Type
series a
Investors
Description
Combat Medical has successfully completed the first close of its Series A financing, raising £2.6 million. The funding will propel the pivotal FDA registration trial for its innovative HIVEC treatment targeting BCG unresponsive bladder cancer. This financing round is led by T&J Meyer Family Foundation along with Varia Ventures and other investors. Combat aims to scale operations and expand its clinical programs as they work towards FDA approval.
Related People
Funding Insights
Based on industry dataWatching Combat Medical? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan